Clinical Trial

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is being done to obtain descriptive classifications of pruritus using a patient directed survey system and assess change in pruritus over time in patients with Atopic Dermatitis over 4 weeks with use of topical Roflumilast cream 0.15% QD.
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-14
Trial Details
NCT Number NCT07560618
Lead Sponsor Integrative Skin Science and Research
Collaborators: Arcutis Biotherapeutics, Inc.
Conditions ITCH, Atopic Dermatitis
Enrollment 40 participants
Start Date 2026-07-21
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-13